Abstract
IL-9 is a pro-inflammatory cytokine implicated in certain immune-mediated diseases where chronic or acute inflammation of the mucosa plays an important role. Although initially described as being produced by what was then thought to be Th2 cells, it was later described that specialized lymphocyte populations are involved in IL-9 production. In addition to the classical Th9 effector (subset of CD4+ T cells), IL-9 is also produced by nonconventional lymphocytes, namely invariant natural killer T (iNKT) cells and innate lymphoid cells (ILCs). The identification of IL-9-producing cells by flow cytometry and cytokine measurements are pivotal for assigning and defining functional cellular phenotypes. In this chapter we provide methods for the in vitro polarization of IL-9-producing nonconventional lymphocytes and the best conditions for the detection of IL-9 production by intracellular staining.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Uyttenhove C, Simpson RJ, Van Snick J (1988) Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A 85:6934–6938. doi:10.1073/pnas.85.18.6934
Simpson RJMR, Rubira MR, Gorman JJ, Van Snick J (1989) Complete amino acid sequence of a new murine T-cell growth factor P40. Eur J Biochem 183:715–722
Schmitt E, Van Brandwijk R, Van Snick J, Siebold B, Rüde E (1989) TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. Eur J Immunol 19:2167–2170. doi:10.1002/eji.1830191130
Yang YCRS, Ciarletta A, Calvetti J, Kelleher K, Clark SC (1989) Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40. Blood 74:1880–1884
Elyaman WBE, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, Bettelli E, Oukka M, van Snick J, Renauld JC, Kuchroo VK, Khoury SJ (2009) IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A 106:12885–12890
Hültner LKS, Stassen M, Kaspers U, Kremer JP, Mailhammer R, Moeller J, Broszeit H, Schmitt E (2000) In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J Immunol 164:5556–5563
Mohamadzadeh MAK, Sugamura K, Bergstresser PR, Takashima A (1996) Expression of the common cytokine receptor gamma chain by murine dendritic cells including epidermal Langerhans cells. Eur J Immunol 26:156–160
Veldhoen MUC, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B (2008) Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9:1341–1346. doi:10.1038/ni.1659
Schmitt EGT, Goedert S, Hoehn P, Huels C, Koelsch S, Kühn R, Müller W, Palm N, Rüde E (1994) IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 153:3989–3996
Dardalhon VAA, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, Kuchroo VK (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(−) effector T cells. Nat Immunol 9:1347–1355
Kaplan MHHM, Olson MR (2015) The development and in vivo function of T helper 9 cells. Nat Rev Immunol 15:295–307
Kaplan MH (2013) Th9 cells: differentiation and disease. Immunol Rev 252:104–115
Jash ASA, Kim GC, Chae CS, Hwang JS, Kim JE, Im SH (2012) Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation. J Biol Chem 278:15445–15457
Xiao XBS, Liu W, Chu X, Wang H, Taparowsky EJ, Fu YX, Choi Y, Walsh MC, Li XC (2012) OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol 13:981–990
Zhu YXKL, Luo W, Li CC, Yang L, Yang YC (1996) Multiple transcription factors are required for activation of human interleukin 9 gene in T cells. J Biol Chem 271:15815–15822
Bassil ROW, Olah M, Kurdi AT, Frangieh M, Buttrick T, Khoury SJ, Elyaman W (2014) BCL6 controls Th9 cell development by repressing Il9 transcription. J Immunol 193:198–207
Liao WSR, Li P, Du N, West EE, Ren M, Mitra S, Leonard WJ (2014) Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc Natl Acad Sci U S A 111:3508–3513
Goswami R, Jabeen R, Yagi R, Pham D, Zhu J, Goenka S, Kaplan MH (2012) STAT6-dependent regulation of Th9 development. J Immunol 188:968–975. doi:10.4049/jimmunol.1102840
Chang H-C, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, Jabeen R, McKinley C, Ahyi A-N, Han L, Nguyen ET, Robertson MJ, Perumal NB, Tepper RS, Nutt SL, Kaplan MH (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11:527–534. doi:10.1038/ni.1867
Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET, Attenasio A, Walsh D, Olson MR, Kim MH, Tepper RS, Sun J, Kim CH, Taparowsky EJ, Zhou B, Kaplan MH (2013) Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest 123:4641–4653. doi:10.1172/JCI69489
Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, Gerlitzki B, Hoffmann M, Ulges A, Taube C, Dehzad N, Becker M, Stassen M, Steinborn A, Lohoff M, Schild H, Schmitt E, Bopp T (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33:192–202. doi:10.1016/j.immuni.2010.07.014
Barlow JL, McKenzie ANJ (2014) Type-2 innate lymphoid cells in human allergic disease. Curr Opin Allergy Clin Immunol 14:397–403. doi:10.1097/ACI.0000000000000090
Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12:1055–1062. doi:10.1038/ni.2104
Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, McKenzie ANJ (2012) Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 129:191–198.e191–194. doi:10.1016/j.jaci.2011.09.041
Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H (2012) IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 188:1503–1513. doi:10.4049/jimmunol.1102832
Gold MJ, Antignano F, Halim TYF, Hirota JA, Blanchet M-R, Zaph C, Takei F, McNagny KM (2014) Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 133:1142–1148. doi:10.1016/j.jaci.2014.02.033
Halim TYF, Krauss RH, Sun AC, Takei F (2012) Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36:451–463. doi:10.1016/j.immuni.2011.12.020
Kim HY, Chang Y-J, Subramanian S, Lee H-H, Albacker LA, Matangkasombut P, Savage PB, McKenzie ANJ, Smith DE, Rottman JB, DeKruyff RH, Umetsu DT (2012) Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 129:216–227.e211–216. doi:10.1016/j.jaci.2011.10.036
Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517:293–301. doi:10.1038/nature14189
Hoyler T, Klose CSN, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins EL, Voehringer D, Busslinger M, Diefenbach A (2012) The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37:634–648. doi:10.1016/j.immuni.2012.06.020
Liang H-E, Reinhardt RL, Bando JK, Sullivan BM, Ho I-C, Locksley RM (2012) Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol 13:58–66. doi:10.1038/ni.2182
Wong SH, Walker JA, Jolin HE, Drynan LF, Hams E, Camelo A, Barlow JL, Neill DR, Panova V, Koch U, Radtke F, Hardman CS, Hwang YY, Fallon PG, McKenzie ANJ (2012) Transcription factor RORα is critical for nuocyte development. Nat Immunol 13:229–236. doi:10.1038/ni.2208
Yang Q, Monticelli LA, Saenz SA, Chi AW-S, Sonnenberg GF, Tang J, De Obaldia ME, Bailis W, Bryson JL, Toscano K, Huang J, Haczku A, Pear WS, Artis D, Bhandoola A (2013) T Cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 38:694–704. doi:10.1016/j.immuni.2012.12.003
Bendelac A (1995) Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J Exp Med 182:2091–2096
Constantinides MG, Bendelac A (2013) Transcriptional regulation of the NKT cell lineage. Curr Opin Immunol 25:161–167. doi:10.1016/j.coi.2013.01.003
Monteiro M, Almeida CF, Caridade M, Ribot JC, Duarte J, Agua-Doce A, Wollenberg I, Silva-Santos B, Graca L (2010) Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J Immunol 185:2157–2163. doi:10.4049/jimmunol.1000359
Monteiro M, Almeida CF, Agua-Doce A, Graca L (2013) Induced IL-17-producing invariant NKT cells require activation in presence of TGF-β and IL-1β. J Immunol 190:805–811. doi:10.4049/jimmunol.1201010
Kim HS, Chung DH (2013) IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner. Mucosal Immunol 6:347–357. doi:10.1038/mi.2012.77
Monteiro M, Agua-Doce A, Almeida CF, Fonseca-Pereira D, Veiga-Fernandes H, Graca L (2015) IL-9 expression by invariant NKT cells is not imprinted during thymic development. J Immunol 195:3463–3471. doi:10.4049/jimmunol.1403170
McNab FW, Pellicci DG, Field K, Besra G, Smyth MJ, Godfrey DI, Berzins SP (2007) Peripheral NK1.1 NKT cells are mature and functionally distinct from their thymic counterparts. J Immunol 179:6630–6637
Doull IJ, Lawrence S, Watson M, Begishvili T, Beasley RW, Lampe F, Holgate T, Morton NE (1996) Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 153:1280–1284. doi:10.1164/ajrccm.153.4.8616554
Sordillo JE, Kelly R, Bunyavanich S, McGeachie M, Qiu W, Croteau-Chonka DC, Soto-Quiros M, Avila L, Celedón JC, Brehm JM, Weiss ST, Gold DR, Litonjua AA (2015) Genome-wide expression profiles identify potential targets for gene-environment interactions in asthma severity. J Allergy Clin Immunol 136:885–892.e882. doi:10.1016/j.jaci.2015.02.035
Nouri-Aria KT, Pilette C, Jacobson MR, Watanabe H, Durham SR (2005) IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J Allergy Clin Immunol 116:73–79. doi:10.1016/j.jaci.2005.03.011
Brough HA, Cousins DJ, Munteanu A, Wong YF, Sudra A, Makinson K, Stephens AC, Arno M, Ciortuz L, Lack G, Turcanu V (2014) IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy. J Allergy Clin Immunol 134:1329–1338.e1310. doi:10.1016/j.jaci.2014.06.032
Chen C-Y, Lee J-B, Liu B, Ohta S, Wang P-Y, Kartashov AV, Mugge L, Abonia JP, Barski A, Izuhara K, Rothenberg ME, Finkelman FD, Hogan SP, Wang Y-H (2015) Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food Allergy. Immunity 43:788–802. doi:10.1016/j.immuni.2015.08.020
Liu J, Harberts E, Tammaro A, Girardi N, Filler RB, Fishelevich R, Temann A, Licona-Limón P, Girardi M, Flavell RA, Gaspari AA (2014) IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol 134:1903–1911. doi:10.1038/jid.2014.61
Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, Lehr H-A, Wirtz S, Vieth M, Waisman A, Rosenbauer F, McKenzie ANJ, Weigmann B, Neurath MF (2014) TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol 15:676–686. doi:10.1038/ni.2920
Defendenti C, Sarzi-Puttini P, Saibeni S, Bollani S, Bruno S, Almasio PL, Declich P, Atzeni F (2015) Significance of serum Il-9 levels in inflammatory bowel disease. Int J Immunopathol Pharmacol 28:569–575. doi:10.1177/0394632015600535
Knoops L, Renauld J-C (2004) IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors (Chur) 22:207–215. doi:10.1080/08977190410001720879
Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo VK, Clark RA, Kupper TS (2012) Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 18:1248–1253. doi:10.1038/nm.2856
Pan H-F, Leng R-X, Li X-P, Zheng SG, Ye D-Q (2013) Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases. Cytokine Growth Factor Rev 24:515–522
Rojas-Zuleta WG, Vásquez G (2016) Th9 lymphocytes: A recent history from IL-9 to its potential role in rheumatic diseases. Autoimmun Rev. doi:10.1016/j.autrev.2016.02.020
Perfetto SP, Chattopadhyay PK, Roederer M (2004) Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 4:648–655. doi:10.1038/nri1416
Acknowledgments
We thank Marta Monteiro for her contribution to the iNKT cell work in the lab, including establishing the protocols described in this paper. Work in the host laboratory is supported by Fundação para a Ciencia e Tecnologia (PTDC/SAU-TOX/11424/2009) and FAPESP (FAPESP/19906/2014).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Almeida, S.C.P., Graca, L. (2017). IL-9 Production by Nonconventional T helper Cells. In: Goswami, R. (eds) Th9 Cells. Methods in Molecular Biology, vol 1585. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6877-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6877-0_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6876-3
Online ISBN: 978-1-4939-6877-0
eBook Packages: Springer Protocols